NANOZOLID Trademark

Trademark Overview

On Tuesday, November 1, 2016, a trademark application was filed for NANOZOLID with the United States Patent and Trademark Office. The USPTO has given the NANOZOLID trademark a serial number of 79199498. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2019. This trademark is owned by Lidds AB. The NANOZOLID trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemico-pharmaceutical preparations for local treatment of cancer tumors; medicines and pharmaceutical preparations with controlled release for treating cancer tumors; drug delivery agents that provide controlled release of the active ingredients for pharmaceuticals for the treatment of cancer tumors

Nanotechnology research related to the treatment of cancer tumors; development of technology for controlling the release of medicines for the treatment of cancer tumors
nanozolid

General Information

Serial Number79199498
Word MarkNANOZOLID
Filing DateTuesday, November 1, 2016
Status700 - REGISTERED
Status DateTuesday, August 13, 2019
Registration Number5830505
Registration DateTuesday, August 13, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements

Goods and ServicesChemico-pharmaceutical preparations for local treatment of cancer tumors; medicines and pharmaceutical preparations with controlled release for treating cancer tumors; drug delivery agents that provide controlled release of the active ingredients for pharmaceuticals for the treatment of cancer tumors
Goods and ServicesNanotechnology research related to the treatment of cancer tumors; development of technology for controlling the release of medicines for the treatment of cancer tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 6, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 6, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLidds AB
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressSE
Party NameLidds AB
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressSE
Party NameLidds AB
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressSE

Trademark Events

Event DateEvent Description
Wednesday, February 8, 2017ASSIGNED TO EXAMINER
Thursday, January 5, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 10, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, February 15, 2017NON-FINAL ACTION WRITTEN
Thursday, February 16, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 16, 2017REFUSAL PROCESSED BY MPU
Thursday, February 16, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 3, 2017REFUSAL PROCESSED BY IB
Thursday, June 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 22, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 15, 2017SUSPENSION LETTER WRITTEN
Thursday, January 25, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 6, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, July 15, 2017LETTER OF SUSPENSION E-MAILED
Saturday, July 15, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 25, 2018ASSIGNED TO LIE
Wednesday, February 14, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 28, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 8, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 22, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, September 4, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, September 9, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, November 13, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 6, 2019FINAL DISPOSITION PROCESSED
Friday, December 6, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 13, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 27, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 31, 2019NOTIFICATION PROCESSED BY IB

Related Keywords

nanozolid tumors cancer treatment release controlled medicines pharmaceutical preparations research nanotechnology